![James Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Hall
Algemeen Directeur bij
Balticgruppen Bio AB
Health Technology
Profiel
James Hall is Chief Executive Officer at Betagenon AB since 2021.
Formerly, Dr. Hall was Chief Executive Officer at Athera Biotechnologies AB from 2019 to 2021.
Dr. Hall also served as Chief Executive Officer at Amplifier TX AB.
Actieve functies van James Hall
| Bedrijven | Functie | Begin |
|---|---|---|
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Algemeen Directeur | 01-05-2021 |
Eerdere bekende functies van James Hall
| Bedrijven | Functie | Einde |
|---|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Algemeen Directeur | 01-04-2021 |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Balticgruppen Bio AB
Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Health Technology |
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Health Technology |
